4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Ipratropium bromide: new trials by email Literature Review of Ipratropium bromide trials Research Report on Ipratropium bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Actuation Indicator Trial in Patients With COPD Ipratropium bromide - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 142 | 2009-06-01 | 2014-07-02 |
| Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Budesonide, albuterol, Ipratropium bromide - Asthma | Phase 3 | Completed | Northwell Health | 95 | 2007-09-01 | 2016-01-21 |
| Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Ipratropium bromide, Magnesium Sulfate - COPD Exacerbation | Phase 3 | Completed | University of Monastir | 124 | 2005-01-01 | 2010-06-03 |
| Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease Ipratropium bromide / Salbutamol, Placebo Inhalation solution, Ipratropium bromide - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 1118 | 2002-10-01 | 2014-06-27 |
Pulmonary Disease, Chronic Obstructive (2) · Asthma (1) · Emergencies (1)
Boehringer Ingelheim (2) · Northwell Health (1) · University of Monastir (1)
United States (2) · Tunisia (1)